Category Archives: TB

TB training for just 5 to 9 percent of private pharmacies not enough for public health impact

By on .

The following is a guest post by Emily Demotte Lisinopril 20 mg by mouth at eight AM? Check. Having already verified the patient’s identification, I scanned the medication barcodes into the computer one by one, performing the third, and final, confirmation of the “five rights” of medication administration – right patient, right drug, right dose, […]

Stalled TB drug gets new chance with agreement between Johns Hopkins and UN-backed organization

By on .

License agreement with Medicine Patent Pool will speed clinical development of drug considered promising for improved treatment of tuberculosis responsive and resistant to existing drugs With all regimens to treat tuberculosis requiring multiple drugs, and all but two of those drugs tracing their lineage to the middle of the last century, excitement was high in […]

Raise profile, funding of global TB response to match advances seen in HIV, Malaria efforts report says

By on .

Over the first 15 years of this century, as efforts against the “big three” global infectious diseases — HIV, malaria and tuberculosis — accelerated, the numbers of new HIV infections dropped by 32 percent, and the number of deaths caused by the virus declined by 31 percent. Malaria infections dropped by 18 percent, and deaths […]

Petition asks BRICS to triple TB R&D funding

By on .

Global tuberculosis treatment advocates and activists are asking leaders of the five countries that are home to almost half of all tuberculosis illnesses and deaths to triple their funding for research and development of new medicines and technologies to prevent, diagnose, and treat the leading infectious disease killer worldwide, on a petition that will be […]

WHO Global TB report: New data raises estimates of illness, death

By on .

While more than half a million fell ill with drug-resistant tuberculosis requiring second-line treatments last year, just one in five received it Improved data collection shows a larger than previously estimated global disease burden and toll of tuberculosis, while progress against the disease remains stalled, the World Health Organization’s 2016 Global Tuberculosis Report shows. The […]

Stephen Lawn: Brought faith, humor, love for Africa, and unending determination to quest for answers to TB, HIV

By on .

Professor Stephen Lawn, physician researcher, author, and teacher, March 13,1966 – Sept. 23, 2016 It was an expedition across the Sahara desert in the late 1980s, Stephen Lawn said later, that changed the course of his life, to one driven by faith and ultimately focused on fighting the impacts of HIV and tuberculosis. The career […]

Zimbabwe study sees TB go down as HIV treatment coverage goes up

By on .

If national health programmers and policy makers are looking for reasons to put into practice World Health Organization recommendations that all people with HIV have access to immediate antiretroviral treatment, a study from Zimbabwe supplies one more: As the numbers of people accessing HIV treatment went up in that country, the numbers of reported tuberculosis […]

UN General Assembly recognizes antimicrobial resistance as global public health threat

By on .

Declaration flags resistance to antibiotics, including for TB treatment, as “greatest and most urgent global risk” Emphasizing imperatives to strengthen local health surveillance and service capacities worldwide, for biomedical research and development driven by evidence and needs, and for collaborations between human health, veterinary, and environmentally related disciplines, the member nations of the United Nations […]

Underfunded tuberculosis programs often solely responsible for TB-HIV activities, report finds

By on .

While tuberculosis remains the number one killer of people living with HIV – with one in three HIV-related deaths attributable to tuberculosis – the burden to provide TB-HIV integrated services falls heavily on tuberculosis programs, not HIV programs, a report from Action finds. The report, “From Policy to Practice: How the TB-HIV response is working,” […]

Multi-country survey sheds light on drug-resistant tuberculosis treatment needs

By on .

Findings highlight gaps in available testing, regimens The first survey to assess tuberculosis that does not respond to common treatments across populations in multiple high-disease-burden countries shows a need for better understanding of the dynamics of drug-resistant disease, including through tests that do not yet exist. The survey’s findings, detailed in The Lancet Infectious Diseases, […]